These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16855347)

  • 41. Laboratory tests for the diagnosis of heparin-induced thrombocytopenia.
    Walenga JM; Jeske WP; Fasanella AR; Wood JJ; Bakhos M
    Semin Thromb Hemost; 1999; 25 Suppl 1():43-9. PubMed ID: 10357151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
    Alving BM; Krishnamurti C
    Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A colorimetric, metabolic dye reduction assay detects highly activated platelets: application in the diagnosis of heparin-induced thrombocytopenia.
    Prechel MM; Escalante V; Drenth AF; Walenga JM
    Platelets; 2012; 23(1):69-80. PubMed ID: 21736539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism].
    Samama MM; Elalamy I; Lecrubier C; Potevin F; Horellou MH; Conard J
    Bull Acad Natl Med; 1998; 182(7):1517-33; discussion 1534-6. PubMed ID: 9916345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
    Janatpour KA; Gosselin RC; Dager WE; Lee A; Owings JT; Zhou J; Wun T
    Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and management of heparin-induced thrombocytopenia.
    Kouides PA; Fricke W
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):335-45. PubMed ID: 15853606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical study of heparin-induced thrombocytopenia].
    Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients: safety of resuming heparin after disappearance of HIT antibodies.
    Hartman V; Malbrain M; Daelemans R; Meersman P; Zachée P
    Nephron Clin Pract; 2006; 104(4):c143-8. PubMed ID: 16902310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
    Francis JL
    Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia.
    Januzzi JL; Jang IK
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():7-11. PubMed ID: 11155189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies.
    Warkentin TE
    Hamostaseologie; 2020 Nov; 40(4):472-484. PubMed ID: 33091948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-induced thrombocytopenia.
    Visentin GP; Liu CY
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):685-96, vi. PubMed ID: 17666285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry.
    Chen Q; Li F; Wang H; Bu C; Shi F; Jin L; Zhang Q; Chi L
    Front Mol Biosci; 2022; 9():966754. PubMed ID: 36090049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Challenges to the design and execution of controlled clinical studies of anticoagulants in patients with heparin-induced thrombocytopenia: lessons learned.
    Boyce SW
    J Thromb Thrombolysis; 2012 Jan; 33(1):124-8. PubMed ID: 21918906
    [No Abstract]   [Full Text] [Related]  

  • 59. [Heparin tolerance test in vitro; hypocoagulability test, its application in diagnosis of hemorrhagic syndromes; hypercoagulability test, its application in the diagnosis of thrombosis].
    SOULIER JP; LE BOLLOCH AG
    Rev Hematol; 1950; 5(2):148-79. PubMed ID: 15430757
    [No Abstract]   [Full Text] [Related]  

  • 60. [The heparin tolerance test in vitro; its prophylactic importance in states of hypercoagulability of the blood].
    MACCHIORO G; WEIS F
    Rass Giuliana Med; 1953 Jan; 9(1):7-15. PubMed ID: 13056193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.